SCHEMBL30396500

SCHEMBL30396500

C#C[C@H](C[C@@H]1CCNC1=O)NC(=O)OCCCC

nearest known ligand 0.56

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 3/20 0.42
▸ CTSB P07858 2/20 0.42
▸ NAAA Q02083 2/20 0.40
▸ CAPN1 P07384 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4648177 0.82 CTSL (0.47) CTSLCTSBNAAACAPN1
SCHEMBL25435650 0.82 CTSL (0.47) CTSLCTSBNAAACAPN1
SCHEMBL29332822 0.81 CTSS (0.41) —
SCHEMBL24189177 0.81 CTSS (0.41) —
SCHEMBL30140807 0.79 CTSL (0.45) CTSLCTSBCAPN1
SCHEMBL31644645 0.79 CTSL (0.45) CTSLCTSBCAPN1
SCHEMBL25278251 0.78 — —
SCHEMBL25278250 0.78 — —
SCHEMBL25224110 0.78 — —
SCHEMBL30877958 0.77 CTSL (0.54) CTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4165037-A1 ANTI-VIRAL COMPOUNDS FOR TREATING CORONAVIRUS, PICORNAVIRUS, AND NOROVIRUS INFECTIONS Aligos Therapeutics, Inc. (US) 2023-04-19 — — EP disclosed
Send feedback